223 related articles for article (PubMed ID: 21062853)
1. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia.
van de Stadt LA; van der Horst AR; de Koning MH; Bos WH; Wolbink GJ; van de Stadt RJ; Pruijn GJ; Dijkmans BA; van Schaardenburg D; Hamann D
Ann Rheum Dis; 2011 Jan; 70(1):128-33. PubMed ID: 21062853
[TBL] [Abstract][Full Text] [Related]
2. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.
Bos WH; Wolbink GJ; Boers M; Tijhuis GJ; de Vries N; van der Horst-Bruinsma IE; Tak PP; van de Stadt RJ; van der Laken CJ; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2010 Mar; 69(3):490-4. PubMed ID: 19363023
[TBL] [Abstract][Full Text] [Related]
3. A prediction rule for the development of arthritis in seropositive arthralgia patients.
van de Stadt LA; Witte BI; Bos WH; van Schaardenburg D
Ann Rheum Dis; 2013 Dec; 72(12):1920-6. PubMed ID: 23178208
[TBL] [Abstract][Full Text] [Related]
4. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
5. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
Bos WH; Ursum J; de Vries N; Bartelds GM; Wolbink GJ; Nurmohamed MT; van der Horst-Bruinsma IE; van de Stadt RJ; Crusius JB; Tak PP; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2008 Sep; 67(9):1347-50. PubMed ID: 18388157
[TBL] [Abstract][Full Text] [Related]
6. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
[No Abstract] [Full Text] [Related]
7. The ACPA recognition profile and subgrouping of ACPA-positive RA patients.
Willemze A; Böhringer S; Knevel R; Levarht EW; Stoeken-Rijsbergen G; Houwing-Duistermaat JJ; van der Helm-van Mil AH; Huizinga TW; Toes RE; Trouw LA
Ann Rheum Dis; 2012 Feb; 71(2):268-74. PubMed ID: 21998120
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
9. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis.
van der Woude D; Rantapää-Dahlqvist S; Ioan-Facsinay A; Onnekink C; Schwarte CM; Verpoort KN; Drijfhout JW; Huizinga TW; Toes RE; Pruijn GJ
Ann Rheum Dis; 2010 Aug; 69(8):1554-61. PubMed ID: 20448290
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis.
van Baarsen LG; Bos WH; Rustenburg F; van der Pouw Kraan TC; Wolbink GJ; Dijkmans BA; van Schaardenburg D; Verweij CL
Arthritis Rheum; 2010 Mar; 62(3):694-704. PubMed ID: 20131234
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
[TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
[TBL] [Abstract][Full Text] [Related]
13. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
[TBL] [Abstract][Full Text] [Related]
14. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
15. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
16. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
17. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
Ioan-Facsinay A; Willemze A; Robinson DB; Peschken CA; Markland J; van der Woude D; Elias B; Ménard HA; Newkirk M; Fritzler MJ; Toes RE; Huizinga TW; El-Gabalawy HS
Arthritis Rheum; 2008 Oct; 58(10):3000-8. PubMed ID: 18821680
[TBL] [Abstract][Full Text] [Related]
18. Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope.
Vander Cruyssen B; Hoffman IE; Peene I; Union A; Mielants H; Meheus L; De Keyser F
Ann Rheum Dis; 2007 Mar; 66(3):364-9. PubMed ID: 16840502
[TBL] [Abstract][Full Text] [Related]
19. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
